Successful Hep-C Combo May Elude Patients as Gilead Goes Solo

Successful Hep-C Combo May Elude Patients as Gilead Goes Solo

David Paul Morris/Bloomberg

An automated machine works on purification of a potential hepatitis C virus drug candidate at the Gilead Sciences Inc. lab in Foster City, California.